Sign In
Buy BOXL
$3.04
+0.210 (+7.42%)
At Close: Jul 31, 2026
Boxlight's Clevertouch Gains Market Share in Australia
08:30am, Wednesday, 30'th Dec 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)-- #Boxlight--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced over $1.75 m
Boxlight's Clevertouch Launches Successful Technology Rollout at NA College
08:30am, Wednesday, 16'th Dec 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)-- #Boxlight--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced a successful
Boxlight's Clevertouch Brand Wins Plus X Award in Four Categories
08:30am, Tuesday, 15'th Dec 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)-- #boxl--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced Clevertouch wins
The 7 Best Penny Stocks Under $3
11:59am, Monday, 14'th Dec 2020
Penny stocks are not for everyone. But if you are willing to take on more risk, there are certainly opportunities for gains.
Boxlight Wins Best of Show Awards at ISTE
08:30am, Monday, 14'th Dec 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced they are the recipients
Boxlight Announces Three New Product Awards
08:30am, Monday, 07'th Dec 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)-- #Boxlight--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced they are the
Boxlight names new chief technology officer and CFO
10:43am, Monday, 30'th Nov 2020
Boxlight Corp. said Monday that it has named Shaun Marklew as chief technology officer and Patrick Foley as chief financial officer, effective Jan. 16, 2021. Both appointments come from Sahara Present
Boxlight Announces Additional Executive Leadership
08:30am, Monday, 30'th Nov 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)-- #Boxlight--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology, digital signage and software solutions, today announced that Shaun M
Boxlight Announces Director of Strategic Funding and Grants
08:30am, Wednesday, 25'th Nov 2020
LAWRENCEVILLE, Ga.--(BUSINESS WIRE)--Boxlight Corporation (Nasdaq: BOXL), a leading provider of interactive technology solutions, today announced that Dr. Don Gemeinhardt has joined Boxlight as Direct
Boxlight Corporation: Buy On Any Earnings-Related Weakness In Preparation For A Much Stronger Close To The Year
08:09am, Tuesday, 17'th Nov 2020
Company reports another disappointing set of quarterly results as both sales and profitability missed expectations. Unfavorable product mix resulted in gross margins taking a major hit. Management pro
Boxlight Corporation's (BOXL) CEO Michael Pope on Q3 2020 Results - Earnings Call Transcript
11:17pm, Monday, 16'th Nov 2020
Boxlight Corporation's (BOXL) CEO Michael Pope on Q3 2020 Results - Earnings Call Transcript
Boxlight: Q3 Earnings Insights
04:31pm, Monday, 16'th Nov 2020
Shares of Boxlight (NASDAQ:BOXL) fell 3.97% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 33.33% over the past year to ($0.02), which missed
Interactive Whiteboard Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2020-2024
12:00am, Wednesday, 21'st Oct 2020
Interactive Whiteboard market will register an incremental spend of about USD 1 billion, growing at a CAGR of 8.45% during the five-year forecast
Genesis Energy, L.P. Sets Date for Release of Third Quarter Results and Conference Call
12:00am, Tuesday, 20'th Oct 2020
Genesis Energy, L.P. (NYSE: GEL) will announce its earnings for the third quarter ended September 30, 2020 on November 5, 2020, before the market open
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
12:00am, Monday, 19'th Oct 2020
Genesis Therapeutics, a privately-held company inventing and deploying state-of-the-art artificial intelligence (AI) techniques to augment drug discov
